AccScience Publishing / GPD / Volume 2 / Issue 1 / DOI: 10.36922/gpd.v1i3.201
Cite this article
25
Download
35
Citations
302
Views
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
REVIEW

Application of artificial intelligence in drug repositioning

Qingkai Hu1* Xianfang Wang2* Yifeng Liu2 Yu Sang1 Dongfang Zhang1
Show Less
1 College of Computer Science and Technology, Henan Institute of Technology, Xinxiang, Henan, 453000, China
2 College of Management, Henan Institute of Technology, Xinxiang, Henan, 453000, China
Submitted: 21 September 2022 | Accepted: 21 October 2022 | Published: 7 November 2022
© 2023 by the Author(s). Licensee AccScience Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

The use of artificial intelligence technologies in biology, pharmacy, and medicine has brought about a dramatic change in these industries. Drug repositioning is a method of drug development in the process of applying existing therapeutic agents to new diseases. This paper first outlines the use of artificial intelligence technology in the field of drug repositioning, then reviews a variety of application methods of artificial intelligence in the realm of drug repositioning, and finally summarizes the advantages and disadvantages of these methods, and proposes the difficulties faced by artificial intelligence in drug repositioning in the future and the corresponding suggestions to achieve the goal of helping researchers to develop more effective methods of drug repositioning.

Keywords
Drug repositioning
Drug targets
Deep learning
Artificial intelligence
Drug target interaction
Funding
National Natural Science Foundation of China
Natural Science Foundation of Henan Province
References
[1]

Peng C, Hu Y, Chen L, et al., 2020, A review of drug repositioning algorithms based on machine learning and big data mining. Adv Pharm, 44(1): 6. 

[2]

Zhang W, Gu F, Fu YK, et al., 2021, Research progress of drug repositioning in new drug development. Anim Husbandry Vet Med, 53(12): 123–127.

[3]

Nelson BS, Kremer DM, Lyssiotis CA, 2018, New tricks for an old drug. Nat Chem Biol, 14: 990–991.

[4]

Li FT, Liu MX, Wang XB, et al., 2022, Progress of COVID-19 drug repositioning study. China Pharm Biotechnol, 17(4): 8.

[5]

Huang F, Yang HF, Zhu X, 2021, Advances in the application of artificial intelligence in new drug discovery. Adv Pharm, 2021(7): 502–511.

[6]

Jarada TN, Rokne JG, Alhajj R, 2020, A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions. J Cheminform, 12(1): 46. https://doi.org/10.1186/s13321-020-00450-7

[7]

Cheng, Fei X, Liu, et al., 2012, Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput Biol, 8(5): e1002503. https://doi.org/10.1371/journal.pcbi.1002503

[8]

Guney E, Menche J, Vidal M, et al., 2016, Network-based in silico drug efficacy screening. Nat Commun, 7(1): 10331. https://doi.org/10.1038/ncomms10331 

[9]

Wang W, Yang S, Zhang X, et al., 2014, Drug repositioning by integrating target information through a heterogeneous network model. Bioinformatics, 30(20): 2923–2930. https://doi.org/10.1093/bioinformatics/btu403 

[10]

Chen, X, Liu, Yan GY, 2012, Drug-target interaction prediction by random walk on the heterogeneous network. Mol Biosyst, 8(7): 1970–1978.

[11]

Olayan RS, Haitham A, Bajic VB, 2018, DDR: Efficient computational method to predict drug–target interactions using graph mining and machine learning approaches. Bioinformatics, 34(7): 1164–1173. https://doi.org/10.1093/bioinformatics/btx731

[12]

Peng J, Li J, Shang X, 2020, A learning-based method for drug-target interaction prediction based on feature representation learning and deep neural network. BMC Bioinformatics, 21(Suppl 13): 394.

[13]

Ji B, You ZH, Jiang HJ, et al., 2020, Prediction of drug-target interactions from multi-molecular network based on LINE network representation method. J Transl Med, 18(1): 347. https://doi.org/10.1186/s12967-020-02490-x

[14]

Lu XG, Liu F, Li JX, et al., 2021, A drug target prediction method based on multi-source data fusion and network structure perturbation CN112420126A. China: Hunan Province.

[15]

He JY, Yang XX, Gong Z, 2021. A computational drug repositioning method based on memory network and attention CN112331275A. China: Jiangsu Province.

[16]

Wang X, Li Q, Liu Y, et al., 2022, Drug repositioning of COVID-19 based on mixed graph network and ion channel. Math Biosci Eng, 19(4): 3269–3284.

[17]

Wall ME, Rechtsteiner A, Rocha LM, 2002, Singular Value Decomposition and Principal Component Analysis. Springer, Germany.

[18]

Shen M, Xiao Y, Golbraikh A, et al., 2003, Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates. J Med Chem, 46(3): 3013–3020. https://doi.org/10.1021/jm020491t

[19]

Susnow RG, Dixon SL, 2003, Use of robust classification techniques for the prediction of human cytochrome P450 2D6 inhibition. J Chem Inform Comput Sci, 43(4): 1308–1315. 

[20]

Christianini N, Shawe-Taylor J, 2002, Support Vector Machines and other Kernel-based Learning Methods. Cambridge University Press, United Kingdom.

[21]

Guengerich FP, 2006, Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J, 8(1): E101–E111.

[22]

Cheng F, Yu Y, Shen J, et al., 2011, Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers. J Chem Inform Model, 51: 996–1011. https://doi.org/10.1021/ci200028n

[23]

Napolitano F, Zhao Y, Moreira VM, et al., 2013, Drug repositioning: A machine-learning approach through data integration. J Cheminform, 5(1): 30.

[24]

Gottlieb A, Stein GY, Ruppin E, et al., PREDICT: A method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol, 7(1): 496. https://doi.org/10.1038/msb.2011.26

[25]

Gönen M, 2012, Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization. Bioinformatics, 28(18): 2304–2310. https://doi.org/10.1093/bioinformatics/bts360

[26]

Aliper A, Plis S, Artemov A, et al., 2016, Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data. Mol Pharm, 13(7): 2524–2530. https://doi.org/10.1021/acs.molpharmaceut.6b00248

[27]

Segler MH, Preuss M, Waller MP, 2018, Planning chemical syntheses with deep neural networks and symbolic AI. Nature, 555(7698): 604–610. https://doi.org/10.1038/nature25978

[28]

Hughes TB, Swamidass SJ, 2017, Deep learning to predict the formation of quinone species in drug metabolism. Chem Res Toxicol, 30(2): 642–656.

[29]

Turk S, Merget B, Rippmann F, et al., Coupling matched molecular pairs with machine learning for virtual compound optimization. J Chem Inform Model, 57(12): 3079–3085.https://doi.org/10.1021/acs.jcim.7b00298

[30]

Zhang L, 2017, Research on Protein Class and Protein- Ligand Interaction Prediction Based on Machine Learning. Shandong University, China.

[31]

Chen P, Bao TJ, Yu SH, 2021, Drug relocation recommendation algorithm based on multi-similarity fusion. Comput Technol Dev, 31(1): 168-174.

[32]

Zhang H, An XY, Liu CH, 2022, Drug knowledge discovery based on multi-source semantic knowledge graphs: Empirical evidence with drug repositioning. Data Anal Knowl Discov, 6(7): 87–98.

[33]

Zeng X, Zhu S, Liu X, et al., 2019, deepDR: A network-based deep learning approach to in silico drug repositioning. Bioinformatics, 35(24): 5191–5198. https://doi.org/10.1093/bioinformatics/btz418

[34]

Xuan P, Song Y, Zhang T, et al., 2019, Prediction of potential drug-disease associations through deep integration of diversity and projections of various drug features. Int J Mol Sci,1 20(17): 4102. 

[35]

Yang M, Luo H, Li Y, et al., 2019, Drug repositioning based on bounded nuclear norm regularization. Bioinformatics, 35(14): i455–i463. https://doi.org/10.1093/bioinformatics/btz331

[36]

Zhang W, Xu H, Li X, et al., 2020, DRIMC: An improved drug repositioning approach using Bayesian inductive matrix completion. Bioinformatics, 36(9): 2839–2847. https://doi.org/10.1093/bioinformatics/btaa062

[37]

Peng LH, Tian XF, Zhou LQ, et al., 2021, A drug-target relationship prediction method based on deep forest and PU learning, CN112652355A. China: Hunan Province.

[38]

Yan Y, Yang M, Zhao H, et al., 2022, Drug repositioning based on multi-view learning with matrix completion. Brief Bioinform, 23(3): bbac054. https://doi.org/10.1093/bib/bbac054

Conflict of interest
The authors declare that they have no competing interests.
Share
Back to top
Gene & Protein in Disease, Electronic ISSN: 2811-003X Print ISSN: TBA, Published by AccScience Publishing